GHK-Cu is the copper(II) complex of glycyl-L-histidyl-L-lysine (Gly-His-Lys), a tripeptide first isolated from human serum albumin in 1973 whose concentration declines with age
An advisory committee to the Food and Drug Administration voted yesterday to recommend that compounding pharmacies be allowed to make the peptide, even though it has little human-safety data and hasnt passed through the normal FDA drug-approval process
Nutritional Composition Constituents Water, glycerol, phospholipids, sodium L-ascorbate, reduced L-glutathione, mango flavouring, dragon fruit flavouring, sea buckthorn extract, rosemary extract, malic acid
Importantly, the observation that CT+LipRSV animals also displayed impaired social interaction parameters suggests that the formulation itself may influence behavioral responses independently of prenatal VPA exposure
In laboratory research, GHKCU Vial serves as a model compound to investigate coppermediated pathways in extracellular matrix regulation and cellular processes
GSH exposure triggered shRNA release, significantly downregulating target genes and enhancing chemotherapy efficacy in drug-resistant MCF-7 tumor models